KKR raises $4bn for healthcare fund
KKR touted the close of its second dedicated healthcare growth equity investment fund that will target opportunities primarily in North America and Europe.
The KKR Health Care Strategic Growth Fund II raised $4 billion and follows the firm’s first vehicle that closed in November 2017 with $1.45 billion in capital commitments. The strategy is to invest in health care companies with proven products and services that are seeking a partner to commercialize and scale.
Keeping with a diversified portfolio approach, the latest KKR fund will invest in biopharmaceutical, medical device, healthcare services, life . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.
Monthly subscriptions and discounted corporate plans for up to 100 members also available.
